Equities

Inspire Medical Systems Inc

Inspire Medical Systems Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)186.19
  • Today's Change1.42 / 0.77%
  • Shares traded406.41k
  • 1 Year change+34.99%
  • Beta1.3242
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 20-Nov-24
Select bar for recommendation details.
Recommendations20-Nov-24
Buy3
Outperform11
Hold5
Sell0
Strong Sell0

Share price forecast in USD

The 16 analysts offering 12 month price targets for Inspire Medical Systems Inc have a median target of 251.00, with a high estimate of 270.00 and a low estimate of 197.00. The median estimate represents a 34.81% increase from the last price of 186.19.
High45.0%270.00
Med34.8%251.00
Low5.8%197.00

Earnings history & estimates in USD

On Nov 04, 2024, Inspire Medical Systems Inc reported 3rd quarter 2024 earnings of 0.600 per share. This result exceeded the 0.08 consensus of the 17 analysts covering the company and outperformed last year's 3rd quarter results by 0.89.
The next earnings announcement is expected on Feb 04, 2025.
Average growth rate+87.50%
Inspire Medical Systems Inc reported annual 2023 losses of -0.72 per share on Feb 06, 2024.
Average growth rate+9.12%
More ▼

Revenue history & estimates in USD

Inspire Medical Systems, Inc. had 3rd quarter 2024 revenues of 203.19m. This bettered the 197.60m consensus of the 17 analysts covering the company. This was 58.87% above the prior year's 3rd quarter results.
Average growth rate+8.48%
Inspire Medical Systems, Inc. had revenues for the full year 2023 of 624.80m. This was 53.19% above the prior year's results.
Average growth rate+67.71%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.